March 2025 Price Concessions 3rd Update
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (28/03/2025) announced the following list of price concessions for March 2025:
| Drug | Pack size | Price concession |
| Buprenorphine 8mg sublingual tablets sugar free | 7 | £6.39 |
| Calcium and Ergocalciferol tablets | 28 | £7.41 |
| Chloramphenicol 1% eye ointment | 4 | £3.08 |
| Clomethiazole 192mg capsules | 60 | £34.44 |
| Isosorbide mononitrate 10mg tablets | 56 | £3.25 |
| Methylphenidate 10mg tablets | 30 | £5.49 |
| Ondansetron 8mg tablets | 10 | £3.93 |
| Oxybutynin 5mg tablets | 56 | £2.90 |
| Ramipril 2.5mg tablets | 28 | £1.19 |
| Ursodeoxycholic acid 300mg tablets | 60 | £54.22 |
| Verapamil 80mg tablets | 84 | £2.20 |
For the full list of price concessions granted for March 2025 so far please visit our price concession hub page here.
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
We encourage pharmacy teams to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) Please see our latest funding and reimbursement short videos for further information on the recent changes to the price concession process.
